Other
Cost
Vertex Pharmaceuticals Cost remained flat by 0.0% to $25.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 58.3%, from $60.00M to $25.00M. Over 5 years (FY 2020 to FY 2025), Cost shows a downward trend with a -13.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
How to read this metric
Changes in this cost basis reflect the bank's strategic decision to increase or decrease its direct equity investment holdings.
Detailed definition
This represents the original cost basis of equity securities that are measured at fair value through net income. It prov...
Peer comparison
Standard accounting disclosure for equity investments under current fair value accounting standards.
Metric ID:
other_equity_securities_fv_ni_costHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.43M | $69.42M | $69.40M | $69.40M | $69.40M | $104.40M | $104.40M | $129.40M | $72.10M | $72.10M | $72.10M | $72.10M | $72.10M | $72.10M | $72.10M | $60.00M | $60.00M | $25.00M | $25.00M | $25.00M |
| QoQ Change | — | +35.0% | -0.0% | +0.0% | +0.0% | +50.4% | +0.0% | +23.9% | -44.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -16.8% | +0.0% | -58.3% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +34.9% | +50.4% | +50.4% | +86.5% | +3.9% | -30.9% | -30.9% | -44.3% | +0.0% | +0.0% | +0.0% | -16.8% | -16.8% | -65.3% | -65.3% | -58.3% |
Range$25.00M – $129.40M
CAGR-14.1%
Avg YoY Growth-6.4%
Median YoY Growth-8.4%
Current Streak2 quarters growth
Cost at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's cost?
- Vertex Pharmaceuticals (VRTX) reported cost of $25.00M in Q1 2026.
- How has Vertex Pharmaceuticals's cost changed year-over-year?
- Vertex Pharmaceuticals's cost decreased by 58.3% year-over-year, from $60.00M to $25.00M.
- What is the long-term trend for Vertex Pharmaceuticals's cost?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's cost has grown at a -13.4% compound annual growth rate (CAGR), from $51.43M to $25.00M.
- What does cost mean?
- The original purchase price of equity investments that are valued through the income statement.